The efficacy of premedication with 10 mg versus 20 mg of intravenous dexamethasone for prevention of paclitaxel hypersensitivity reaction in low-risk gynecologic cancer patients: a non-inferiority, randomized controlled mono-institutional trial
Dexamethasone 10 mg was non-inferior to dexamethasone 20 mg in terms of prevention of paclitaxel hypersensitivity reactions.
Authors
- Prapaporn Suprasert (ORCID: https://orcid.org/0000-0002-0205-2280)
- Chaiyut Charoentum (ORCID: https://orcid.org/0000-0001-8659-8629)
- Nutthakarn Sa-Ngiamphorn (ORCID: https://orcid.org/0000-0003-4328-8182)
Institutions
- Chiang Mai University (TH)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-08-16
- DOI
- https://doi.org/10.1186/s12885-025-14769-7
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chiang Mai University
- Faculty of Medicine, Chiang Mai University